Harshit Singh, Alok Saxena, and Saksham Tuli, “CONFLICT BETWEEN BRAND NAME DRUGS AND THEIR GENERIC ADAPTATIONS”, Int. J. of Legal. Dev. & Allied Issues., vol. 4, no. 5, pp. 483–495, Oct. 2018, doi: 10.55662/.